Organigram’s Q4 sales hit $31.22 million, boosted by recreational and international growth, with adjusted gross margin improving to 37% of net revenue.
Cannabis Player Organigram Clocks Q4 Gross Margin Of 37% On Higher Efficiency Across Cultivation And Higher Recreational Sales, Stock Soars
